Naba Al Saha Medical Services Company (TADAWUL: 9546)
Saudi Arabia
· Delayed Price · Currency is SAR
77.90
+0.90 (1.17%)
Dec 19, 2024, 2:57 PM AST
Naba Al Saha Medical Services Company Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 37.66 | 52.38 | 26.92 | 25.83 | 26.65 |
| Depreciation & Amortization | 10.1 | 9.27 | 6.7 | 6.12 | 6.09 |
| Other Amortization | 0.23 | 0.23 | 0.06 | - | - |
| Asset Writedown & Restructuring Costs | -2.33 | -2.33 | - | - | - |
| Loss (Gain) on Equity Investments | 1.02 | 0.72 | 0.13 | - | - |
| Provision & Write-off of Bad Debts | - | - | 0.75 | - | - |
| Other Operating Activities | 3.99 | -6.48 | 2.76 | 1.5 | 2.76 |
| Change in Accounts Receivable | -22.84 | -49.4 | 1.82 | -1.13 | -29.25 |
| Change in Inventory | -4.38 | -4.49 | 0.26 | -0.79 | -0.61 |
| Change in Accounts Payable | -0.8 | 17.15 | -2.08 | 2.42 | -1.03 |
| Change in Other Net Operating Assets | 13.19 | 12.32 | -1.84 | -3.22 | 1.41 |
| Operating Cash Flow | 35.84 | 29.36 | 35.5 | 30.74 | 6.04 |
| Operating Cash Flow Growth | 3.86% | -17.30% | 15.49% | 409.26% | - |
| Capital Expenditures | -54.34 | -38.87 | -7.55 | -10.36 | -39.64 |
| Cash Acquisitions | -1.13 | -18.11 | - | - | - |
| Sale (Purchase) of Intangibles | -0.05 | -0.15 | - | - | - |
| Investment in Securities | -1 | -1 | -2.83 | - | - |
| Investing Cash Flow | -59.01 | -60.61 | -13.88 | -10.36 | -39.64 |
| Short-Term Debt Issued | - | - | - | - | 34.83 |
| Long-Term Debt Issued | - | 30.06 | - | - | - |
| Total Debt Issued | 34.32 | 30.06 | - | - | 34.83 |
| Long-Term Debt Repaid | - | -4.79 | -12.69 | -15.17 | -1.69 |
| Net Debt Issued (Repaid) | 25.47 | 25.28 | -12.69 | -15.17 | 33.14 |
| Common Dividends Paid | -2.1 | -2.1 | -2.1 | - | -1.75 |
| Financing Cash Flow | 23.37 | 23.18 | -14.79 | -15.17 | 31.39 |
| Net Cash Flow | 0.2 | -8.08 | 6.83 | 5.21 | -2.21 |
| Free Cash Flow | -18.5 | -9.51 | 27.95 | 20.37 | -33.6 |
| Free Cash Flow Growth | - | - | 37.19% | - | - |
| Free Cash Flow Margin | -9.40% | -5.21% | 21.55% | 17.31% | -29.05% |
| Free Cash Flow Per Share | -1.76 | -0.91 | 2.66 | 1.94 | - |
| Cash Interest Paid | 0.01 | 0.21 | - | - | - |
| Levered Free Cash Flow | -37.44 | -33.17 | 15.96 | 14.89 | - |
| Unlevered Free Cash Flow | -37.31 | -33.04 | 16.1 | 15.05 | - |
| Change in Net Working Capital | 18.18 | 30.92 | 1.75 | -1.9 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.